Atopic Dermatitis and Comorbidity

• Published in: Healthcare (Basel) 2020-03, Vol.8 (2), p.70
• Main Authors: Bekić, Sanja, Martinek, Vjenceslav, Talapko, Jasminka, Majnarić, Ljiljana, Vasilj Mihaljević, Mila, Škrlec, Ivana
• Format: Article
• Language: English
• Subjects: Allergies; Anxiety disorders; Asthma; Atopic dermatitis; atopic march; Comorbidity; Complications and side effects; Dermatitis; Development and progression; Drug therapy; Eczema; Genes; Immunology; Infections; Mental disorders; Mutation; Pathogenesis; Proteins; psychological stress; Risk factors; Statistical analysis; Statistics; Stress; Viral infections
• ISSN: 2227-9032; 2227-9032
• DOI: 10.3390/healthcare8020070

Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and comorbidity in family medicine. In the specialist family medicine practice Osijek, a retrospective study was conducted in the period from January 1, 2016 to July 1, 2017 on the percentage of patients with atopic dermatitis in the total number of patients, and their comorbid diseases. The data source was the E-chart. The results showed that 195 (10.53%) out of 2056 patients had atopic dermatitis, 80 (41%) patients had atopic dermatitis and allergic rhinitis, 34 (17.4%) asthma, 132 (67.7%) infections, 59 (30.3%) gastrointestinal disturbances, and 68 (34.3%) had mental disorders. Patients up to 18 years old were more likely to have infections, and adult patients were exposed to chronic stress. The most commonly used drug was loratadine (60.5%), while mometasone was the most commonly administered topical drug (40%). The result of this research showed the steps of the ˝atopic march˝. Atopic dermatitis is followed by changes in the skin and its progression to other organ systems in most of the patients.